DOCS Klasa A Doximity, Inc. Class A Common Stock
NYSE · Health Care · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 6, 2026
$27,93
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$17,1552tyg. minimum
$74,3352tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$5.02B
P/E (TTM)
33.2
EPS (TTM)
$0.84
Przychody (TTM)
$656M
Twoje odznaki
Zakres 52 tyg.
$17–$74
Ocena Analityków
HOLD
Cena Docelowa
$30
P/E
33.2
ROE
17.2%
Marża Zysku Netto
25.5%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
DOCS Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$27.93
Kapitalizacja Rynkowa (MRQ)
$5.02B
P/E (TTM)
33.2
EPS (TTM)
$0.84
Przychody (TTM)
$656M
ROE (TTM)
17.2%
Zakres 52 tyg.
$17–$74
DOCS Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
O Doximity, Inc. Class A Common Stock Przegląd firmy z Wikipedii
Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.
History
The company was launched in March 2011 by co-founders Nate Gross, Jeff Tangney and Shari Buck. In 2013, founder Jeff Tangney remained CEO while the company was based in San Mateo, California. By 2013, it became one of the largest networks for U.S. healthcare professionals, with approximately 10 percent of U.S. doctors as members.
By the beginning of 2014, 40 percent of U.S. physicians became members. In 2016, it began offering a free service for doctors to call patients using their work number on their mobile phones. In 2018, the company announced that it had reached 1 million members, accounting for more than 70 percent of U.S. physicians. In 2021, Doximity served more than 2 million registered members, including over 80 percent of U.S. physicians and over 50 percent of nurse practitioners and physician assistants.
In 2016, the company was ranked #6 on the Deloitte Technology Fast 500 list. In November 2019, Doximity was listed on the Deloitte Technology Fast 500 list for the fourth consecutive year. In May 2020, the company added video. Dialer Video, a video telehealth app, allows physicians to video call patients through personal smartphones. In June 2020, Doximity Acquires THMED and launches the Curative Brand. Curative is a staffing and recruiting company offering permanent and Locum/Temporary placement services.
In May 2021, Doximity, a professional network for physicians with telehealth and scheduling tools, filed for an initial public offering (IPO) seeking to raise $100 million. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities were the lead underwriters for the IPO. Doximity raised nearly $606 million in its IPO. In its June 2021 IPO on the NYSE, gave it a market cap shortly after its debut of $9.4 billion.
In 2021 August, CNBC reported that the site's news feed was "inundated" with vaccine misinformation shared among physicians, despite Doximity's community guidelines banning medical misinformation. At the time, 80% of its revenue came from ads paid by pharmaceutical firms and hospitals, and directed at physicians on the site. In November 2023, Doximity released DocDefender, a free service that removed a physician's personal phone numbers and addresses from public websites.
Investors
In April 2014, the company announced it had raised a $54 million financing round led by the venture capital firm Draper Fisher Jurvetson and the mutual fund company T. Rowe Price. Morgan Stanley Investment Management also invested. This investment brought Doximity's total funding to $81 million. Doximity received $10.8 million in venture capital funding from Emergence Capital Partners and Interwest Partners in March 2011, and $17 million in Series B funding led by Morgenthaler Ventures in September 2012.
Products and services
Dialer
In 2016, Doximity built Dialer, a free communication tool for physicians to call their patients. The Doximity Dialer app allows physicians to call patients from their personal cell phone, and the patient sees the doctor's office number on caller ID.
Dialer Video
In May 2020, Doximity released Dialer Video, a telemedicine tool that allows physicians to video call their patients directly from their own smartphones. In July 2020, Doximity said that more than 100,000 U.S. Doctors use Dialer Video, its telemedicine app.
Acquisition
In June 2020, Doximity acquired THMED, a healthcare company. Following the purchase, THMED changed its name to Curative and started concentrating on customized medical-personnel queries. In February 2022, Doximity acquired Amion, an on-call doctor scheduling company. In August 2025, Doximity acquired Pathway Medical, a Canadian startup specializing in medical AI and evidence-based clinical reference tools.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
sektorHealth Care
branżaHealth Care
pracownicy880
krajUS
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$645M2020-03-31 → 2026-03-31
EPS$0.982020-03-31 → 2026-03-31
Wolny przepływ pieniężny$326M2022-03-31 → 2026-03-31
Marża netto25.5%2022-03-31 → 2026-03-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | DOCS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 33.2średnia z 5 lat ≈49.8 | ≈49.8 | · | · | |
| P/S (TTM) | 7.7średnia z 5 lat ≈16.1 | ≈16.1 | · | · | |
| P/B (MRQ) | 5.5średnia z 5 lat ≈7.6 | ≈7.6 | · | · | |
| Price / FCF (Cena / FCF) | 15.7średnia z 5 lat ≈39.2 | ≈39.2 | · | · | |
| Price / Cash Flow (Cena / Przepływy pieniężne) | 15.7średnia z 5 lat ≈38.9 | ≈38.9 | · | · | |
| Cena / Wartość księgowa materialna (MRQ) | 5.7średnia z 5 lat ≈8.3 | ≈8.3 | · | · | |
| PEG Ratio (Współczynnik PEG) | ≈1.0 | · | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | DOCS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 88.1%średnia z 5 lat ≈88.9% | ≈88.9% | · | · | |
| Marża Operacyjna (TTM) | 29.6%średnia z 5 lat ≈34.1% | ≈34.1% | · | · | |
| Marża EBITDA (TTM) | 32.0%średnia z 5 lat ≈36.2% | ≈36.2% | · | · | |
| Marża przed opodatkowaniem (TTM) | 34.5%średnia z 5 lat ≈37.8% | ≈37.8% | · | · | |
| Marża Zysku Netto (TTM) | 25.5%średnia z 5 lat ≈34.5% | ≈34.5% | · | · | |
| ROA (TTM) | 14.6%średnia z 5 lat ≈16.9% | ≈16.9% | · | · | |
| ROE (TTM) | 17.2%średnia z 5 lat ≈17.4% | ≈17.4% | · | · | |
| ROIC | 17.7%średnia z 5 lat ≈15.7% | ≈15.7% | · | · |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | DOCS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 6.1średnia z 5 lat ≈6.9 | ≈6.9 | · | · | |
| Quick Ratio (Wskaźnik Szybkości) | 2.3średnia z 5 lat ≈1.9 | ≈1.9 | · | · |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | DOCS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 13.1%średnia z 5 lat ≈26.9% | ≈26.9% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 15.4%średnia z 5 lat ≈21.9% | ≈21.9% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 25.5% | · | · | · | |
| EPS YoY | -11.7%średnia z 5 lat ≈51.7% | ≈51.7% | · | · | |
| Net Income YoY (Zysk Netto R/R) | -12.2%średnia z 5 lat ≈50.2% | ≈50.2% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | 22.7%średnia z 5 lat ≈28.5% | ≈28.5% | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | 33.6% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | 20.2%średnia z 5 lat ≈25.5% | ≈25.5% | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | 31.3% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | DOCS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.5średnia z 5 lat ≈0.5 | ≈0.5 | · | · | |
| Receivables Turnover (Rotacja należności) | 4.7średnia z 5 lat ≈4.8 | ≈4.8 | · | · | |
| Revenue / Employee (Przychody / pracownika) | ≈$732.8K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
3.3%
Następny raport
Lis 04, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | $0.29 | $0.31 | -6.7% | |
| 31 marca 2026 | $0.26 | $0.29 | -10.0% | |
| 31 grudnia 2025 | $0.46 | $0.45 | 1.2% | |
| 30 września 2025 | $0.45 | $0.39 | 16.4% | |
| 30 czerwca 2025 | $0.36 | $0.31 | 17.5% | |
| 31 marca 2025 | $0.46 | $0.45 | 1.2% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $645M | $570M | $475M | $419M | $344M | $207M | $116M | |
| Cost of Revenue | $70M | $56M | $51M | $53M | $40M | $31M | $15M | |
| Gross Profit | $575M | $515M | $425M | $366M | $304M | $176M | $101M | |
| R&D Expense | $131M | $93M | $82M | $80M | $62M | $44M | $32M | |
| SG&A Expense | $65M | $46M | $38M | $37M | $36M | $16M | $7M | |
| Operating Expenses | $360M | $287M | $261M | $240M | $190M | $122M | $79M | |
| Operating Income | $215M | $228M | $164M | $125M | $114M | $53M | $22M | |
| Other Non-op | $-806.0K | $-247.0K | $62.0K | $-146.0K | $-448.0K | $4M | $1M | |
| Pretax Income | $250M | $264M | $185M | $133M | $114M | $58M | $24M | |
| Income Tax | $54M | $40M | $38M | $20M | $-41M | $8M | $-6M | |
| Net Income | $196M | $223M | $148M | $113M | $155M | $50M | $30M | |
| EPS (Basic) | $1.05 | $1.19 | $0.78 | $0.58 | $0.82 | $0.29 | $0.16 | |
| EPS (Diluted) | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 | $0.23 | $0.13 | |
| Shares (Basic) | 187,014,000 | 186,841,000 | 190,172,000 | 193,176,000 | 163,484,000 | 74,342,000 | 66,758,000 | |
| Shares (Diluted) | 199,048,000 | 201,208,000 | 205,734,000 | 213,425,000 | 191,017,000 | 95,134,000 | 81,710,000 | |
| EBITDA | $229M | $238M | $174M | $135M | $119M | · | · |
Bilans
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $219M | $210M | $97M | $158M | $113M | $66M | · | |
| Receivables | $145M | $128M | $101M | $107M | $81M | $50M | · | |
| Prepaid Expense | $51M | $45M | $49M | $27M | $19M | $11M | · | |
| Current Assets | $944M | $1.09B | $913M | $975M | $904M | $209M | · | |
| PP&E (Net) | $18M | $14M | $12M | $11M | $8M | $8M | · | |
| PP&E (Gross) | $49M | $39M | $31M | $25M | $17M | $12M | · | |
| Accum. Depreciation | $31M | $25M | $19M | $14M | $8M | $5M | · | |
| Goodwill | $85M | $68M | $68M | $68M | $19M | $19M | · | |
| Intangibles | $35M | $23M | $27M | $32M | $8M | $10M | · | |
| Other Non-current Assets | $2M | $2M | $1M | $2M | $2M | $3M | · | |
| Total Assets | $1.12B | $1.26B | $1.08B | $1.14B | $991M | $252M | · | |
| Accounts Payable | $4M | $1M | $2M | $1M | $463.0K | $2M | · | |
| Accrued Liabilities | $43M | $38M | $44M | $31M | $25M | $16M | · | |
| Current Liabilities | $155M | $156M | $147M | $140M | $111M | $102M | · | |
| Capital Leases | $8M | $10M | $12M | $14M | $447.0K | $284.0K | · | |
| Other Non-current Liabilities | $9M | $9M | $7M | $1M | $956.0K | $972.0K | · | |
| Total Liabilities | $173M | $182M | $178M | $171M | $113M | $104M | · | |
| Common Stock | $183.0K | $189.0K | $187.0K | $194.0K | $192.0K | $83.0K | · | |
| Paid-in Capital | $1.00B | $894M | $824M | $762M | $703M | $30M | · | |
| Retained Earnings | $-51M | $187M | $80M | $218M | $191M | $36M | · | |
| AOCI | $28.0K | $1M | $-3M | $-14M | $-15M | $-21.0K | · | |
| Stockholders' Equity | $951M | $1.08B | $901M | $966M | $879M | $67M | $1M | |
| Liabilities + Equity | $1.12B | $1.26B | $1.08B | $1.14B | $991M | $252M | · | |
| Shares Outstanding | 183,060,000 | 188,875,000 | 186,562,000 | 193,941,000 | 192,398,000 | 82,910,000 | · |
Przepływy pieniężne
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| D&A | $14M | $11M | $10M | $10M | $5M | $4M | $900.0K | |
| Stock-based Comp | $122M | $72M | $51M | $48M | $31M | $7M | $2M | |
| Deferred Tax | $32M | $-12M | $-9M | $13M | $-41M | $5M | $-7M | |
| Amort. of Intangibles | $6M | $4M | $5M | $5M | $1M | $1M | $0 | |
| Restructuring | · | $2M | $8M | $0 | $0 | · | · | |
| Other Non-cash | $-38M | $-21M | $-16M | $-5M | $-23M | · | · | |
| Operating Cash Flow | $326M | $273M | $184M | $180M | $127M | $83M | $26M | |
| CapEx | $0 | $0 | $147.0K | $2M | $2M | $245.0K | $285.0K | |
| Investing Cash Flow | $147M | $-29M | $31M | $-60M | $-641M | $-70M | $-13M | |
| Stock Repurchased | $432M | $120M | $281M | $85M | $3M | $2M | $0 | |
| Net Stock Activity | $-432M | $-120M | $-281M | $-85M | $-3M | · | · | |
| Financing Cash Flow | $-464M | $-131M | $-277M | $-74M | $560M | $5M | $2M | |
| Net Change in Cash | $10M | $113M | $-61M | $45M | $46M | $18M | $15M | |
| Taxes Paid | $22M | · | · | · | · | · | · | |
| Free Cash Flow | $326M | $273M | $184M | $178M | $125M | · | · |
Rentowność
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 89.1% | 90.2% | 89.3% | 87.2% | 88.4% | · | · | |
| Operating Margin | 33.3% | 39.9% | 34.5% | 29.9% | 33.1% | · | · | |
| Net Margin | 30.4% | 39.1% | 31.0% | 26.9% | 45.1% | · | · | |
| Pretax Margin | 38.8% | 46.2% | 39.0% | 31.8% | 33.2% | · | · | |
| EBITDA Margin | 35.6% | 41.8% | 36.6% | 32.3% | 34.5% | · | · | |
| ROA | 16.4% | 19.1% | 13.3% | 10.6% | 24.9% | · | · | |
| ROE | 19.2% | 21.1% | 16.7% | 11.9% | 18.0% | · | · | |
| ROIC | 17.7% | 17.8% | 14.5% | 11.0% | 17.5% | · | · |
Płynność i wypłacalność
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | 7.0 | 6.2 | 7.0 | 8.1 | · | · | |
| Quick Ratio | 2.3 | 2.2 | 1.3 | 1.9 | 1.7 | · | · |
Efektywność
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.4 | 0.4 | 0.6 | · | · | |
| Receivables Turnover | 4.7 | 5.0 | 4.6 | 4.5 | 5.2 | · | · |
Na akcję
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.19 | $5.73 | $4.83 | $4.98 | $4.57 | · | · | |
| Revenue / Share | $3.24 | $2.83 | $2.31 | $1.96 | $1.80 | · | · | |
| Cash Flow / Share | $1.64 | $1.36 | $0.89 | $0.84 | $0.66 | · | · | |
| Cash / Share | $1.20 | $1.11 | $0.52 | $0.81 | $0.59 | · | · | |
| EPS (TTM) | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 | · | · |
Stopy Wzrostu
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.1% | 20.0% | 13.5% | 22.0% | 66.0% | · | · | |
| Revenue CAGR 3Y | 15.4% | 18.4% | 32.0% | · | · | · | · | |
| Revenue CAGR 5Y | 25.5% | · | · | · | · | · | · | |
| EPS YoY | -11.7% | 54.2% | 35.9% | -24.3% | 204.3% | · | · | |
| EPS CAGR 3Y | 22.7% | 16.6% | 46.3% | · | · | · | · | |
| EPS CAGR 5Y | 33.6% | · | · | · | · | · | · | |
| Net Income YoY | -12.2% | 51.2% | 30.8% | -27.1% | 208.3% | · | · | |
| Net Income CAGR 3Y | 20.2% | 13.0% | 43.2% | · | · | · | · | |
| Net Income CAGR 5Y | 31.3% | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $645M | $570M | $475M | $419M | $344M | · | · | |
| Net Income TTM | $196M | $223M | $148M | $113M | $155M | · | · | |
| Market Cap | $4.27B | $10.96B | $5.02B | $6.28B | $10.02B | · | · | |
| P/E | 23.8 | 52.3 | 37.4 | 61.1 | 74.4 | · | · | |
| P/S | 6.6 | 19.2 | 10.6 | 15.0 | 29.2 | · | · | |
| P/B | 4.5 | 10.1 | 5.6 | 6.5 | 11.4 | · | · | |
| P / Tangible Book | 5.1 | 11.1 | 6.2 | 7.2 | 11.8 | · | · | |
| P / Cash Flow | 13.1 | 40.1 | 27.3 | 35.0 | 79.2 | · | · | |
| P / FCF | 13.1 | 40.1 | 27.3 | 35.3 | 80.4 | · | · | |
| Earnings Yield | 4.2% | 1.9% | 2.7% | 1.6% | 1.3% | · | · |
Rachunek zysków i strat
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $157M | $145M | $185M | $169M | $146M | $138M | $169M | $137M | $127M | $118M | $135M | $114M | $108M | $111M | $115M | $102M | |
| Cost of Revenue | $24M | $19M | $19M | $16M | $16M | $14M | $14M | $14M | $14M | $13M | $12M | $13M | $13M | $14M | $14M | $13M | |
| Gross Profit | $133M | $126M | $166M | $152M | $130M | $124M | $154M | $123M | $113M | $105M | $123M | $101M | $95M | $97M | $102M | $89M | |
| R&D Expense | $38M | $39M | $35M | $30M | $27M | $25M | $22M | $23M | $23M | $20M | $20M | $20M | $22M | $22M | $21M | $19M | |
| SG&A Expense | $16M | $16M | $18M | $19M | $12M | $13M | $14M | $10M | $9M | $10M | $10M | $9M | $9M | $10M | $10M | $9M | |
| Operating Expenses | $99M | $101M | $94M | $88M | $76M | $75M | $74M | $70M | $67M | $64M | $65M | $67M | $66M | $64M | $63M | $57M | |
| Operating Income | $34M | $25M | $72M | $64M | $55M | $49M | $80M | $53M | $46M | $42M | $59M | $34M | $30M | $33M | $38M | $32M | |
| Other Non-op | $-286.0K | $-235.0K | $-158.0K | $-178.0K | $-235.0K | $-51.0K | $-30.0K | $-114.0K | $-52.0K | $73.0K | $-55.0K | $-50.0K | $94.0K | $-27.0K | $-25.0K | $-48.0K | |
| Pretax Income | $40M | $32M | $81M | $73M | $64M | $58M | $90M | $62M | $53M | $48M | $63M | $40M | $35M | $37M | $41M | $33M | |
| Income Tax | $16M | $13M | $19M | $11M | $11M | $-4M | $15M | $18M | $12M | $7M | $15M | $9M | $6M | $6M | $7M | $7M | |
| Net Income | $24M | $19M | $62M | $62M | $53M | $62M | $75M | $44M | $41M | $41M | $48M | $31M | $28M | $31M | $33M | $26M | |
| EPS (Basic) | $0.13 | $0.11 | $0.33 | $0.33 | $0.28 | $0.33 | $0.40 | $0.24 | $0.22 | $0.21 | $0.26 | $0.16 | $0.15 | $0.15 | $0.17 | $0.14 | |
| EPS (Diluted) | $0.13 | $0.09 | $0.31 | $0.31 | $0.27 | $0.31 | $0.37 | $0.22 | $0.21 | $0.20 | $0.24 | $0.15 | $0.13 | $0.15 | $0.16 | $0.12 | |
| Shares (Basic) | 182,569,000 | · | 187,478,000 | 187,705,000 | 187,984,000 | · | 187,161,000 | 186,252,000 | 185,610,000 | · | 186,309,000 | 193,112,000 | 194,521,000 | · | 192,805,000 | 193,137,000 | |
| Shares (Diluted) | 191,169,000 | · | 199,224,000 | 200,745,000 | 201,158,000 | · | 202,233,000 | 200,407,000 | 199,224,000 | · | 200,463,000 | 209,014,000 | 212,355,000 | · | 212,065,000 | 213,949,000 | |
| EBITDA | $38M | · | $72M | $64M | $57M | · | $80M | $53M | $49M | · | $59M | $34M | $32M | · | $38M | $32M |
Bilans
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $274M | $219M | $65M | $169M | $137M | $210M | $165M | $184M | $111M | $97M | $123M | $108M | $307M | · | $136M | $74M | |
| Receivables | $178M | $145M | $157M | $129M | $142M | $128M | $138M | $125M | $121M | $101M | $98M | $97M | $93M | · | $75M | $79M | |
| Prepaid Expense | $49M | $51M | $102M | $85M | $52M | $45M | $30M | $27M | $37M | $49M | $27M | $33M | $20M | · | $17M | $16M | |
| Current Assets | $914M | $944M | $993M | $1.09B | $1.03B | $1.09B | $1.01B | $958M | $908M | $913M | $841M | $863M | $990M | · | $899M | $848M | |
| PP&E (Net) | $19M | $18M | $17M | $16M | $14M | $14M | $13M | $13M | $13M | $12M | $12M | $12M | $12M | · | $12M | $12M | |
| PP&E (Gross) | $53M | $49M | $47M | $43M | $41M | $39M | $37M | $35M | $33M | $31M | $29M | $28M | $26M | · | $24M | $22M | |
| Accum. Depreciation | $34M | $31M | $30M | $28M | $26M | $25M | $23M | $22M | $21M | $19M | $18M | $16M | $15M | · | $12M | $11M | |
| Goodwill | $85M | $85M | $85M | $85M | $68M | $68M | $68M | $68M | $68M | $68M | $68M | $68M | $68M | · | $68M | $68M | |
| Intangibles | $33M | $35M | $37M | $39M | $22M | $23M | $24M | $25M | $26M | $27M | $28M | $29M | $31M | · | $33M | $34M | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $1M | · | $1M | $1M | |
| Total Assets | $1.08B | $1.12B | $1.16B | $1.26B | $1.20B | $1.26B | $1.17B | $1.12B | $1.07B | $1.08B | $1.00B | $1.03B | $1.15B | · | $1.07B | $1.03B | |
| Accounts Payable | $6M | $4M | $5M | $4M | $2M | $1M | $2M | $3M | $2M | $2M | $2M | $714.0K | $582.0K | · | $2M | $1M | |
| Accrued Liabilities | $33M | · | $77M | $34M | $38M | $38M | $43M | $34M | $28M | $44M | $34M | $29M | $32M | · | $33M | $26M | |
| Current Liabilities | $150M | $155M | $150M | $140M | $160M | $156M | $116M | $132M | $135M | $147M | $105M | $123M | $133M | · | $106M | $118M | |
| Capital Leases | $8M | $8M | $9M | $9M | $10M | $10M | $11M | $11M | $12M | $12M | $13M | $13M | $14M | · | $14M | $15M | |
| Other Non-current Liabilities | $10M | $9M | $19M | $12M | $9M | $9M | $9M | $8M | $7M | $7M | $841.0K | $7M | $6M | · | $1M | $1M | |
| Total Liabilities | $168M | $173M | $178M | $162M | $179M | $182M | $141M | $157M | $160M | $178M | $136M | $154M | $163M | · | $137M | $149M | |
| Common Stock | $180.0K | $183.0K | $185.0K | $188.0K | $187.0K | $189.0K | $188.0K | $187.0K | $186.0K | $187.0K | $186.0K | $188.0K | $195.0K | · | $193.0K | $192.0K | |
| Paid-in Capital | $1.04B | $1.00B | $957M | $936M | $907M | $894M | $879M | $863M | $841M | $824M | $808M | $795M | $778M | · | $746M | $731M | |
| Retained Earnings | $-119M | $-51M | $21M | $158M | $117M | $187M | $151M | $95M | $73M | $80M | $61M | $85M | $225M | · | $203M | $170M | |
| AOCI | $-348.0K | $28.0K | $1M | $1M | $1M | $1M | $1M | $3M | $-1M | $-3M | $-5M | $-9M | $-12M | · | $-19M | $-22M | |
| Stockholders' Equity | $916M | $951M | $979M | $1.10B | $1.03B | $1.08B | $1.03B | $961M | $914M | $901M | $865M | $871M | $991M | $966M | $930M | $879M | |
| Liabilities + Equity | $1.08B | $1.12B | $1.16B | $1.26B | $1.20B | $1.26B | $1.17B | $1.12B | $1.07B | $1.08B | $1.00B | $1.03B | $1.15B | · | $1.07B | $1.03B | |
| Shares Outstanding | 179,849,000 | 183,060,000 | 184,992,000 | 188,090,000 | 187,453,000 | 188,875,000 | 187,584,000 | 186,781,000 | 185,704,000 | 186,562,000 | 186,175,000 | 188,518,000 | 194,649,000 | 193,941,000 | 193,252,000 | 192,302,000 |
Przepływy pieniężne
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Stock-based Comp | $37M | $37M | $34M | $29M | $22M | $18M | $19M | $18M | $17M | $12M | $12M | $13M | $14M | $13M | $14M | $11M | |
| Deferred Tax | · | $32M | $0 | · | · | $-14M | $2M | · | · | $-9M | $0 | $0 | $0 | $4M | $9M | $0 | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Restructuring | · | · | · | · | · | $0 | $0 | $2M | · | $0 | $0 | $8M | · | $0 | $0 | $0 | |
| Other Non-cash | $-23M | · | · | · | $-16M | · | · | · | $-20M | · | · | · | $12M | · | · | · | |
| Operating Cash Flow | $42M | $110M | $61M | $94M | $62M | $98M | $65M | $68M | $41M | $64M | $50M | $13M | $57M | $47M | $49M | $40M | |
| CapEx | $62.0K | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $36.0K | $41.0K | $70.0K | $21.0K | $204.0K | $766.0K | |
| Investing Cash Flow | $113M | $138M | $38M | $-32M | $3M | $-24M | $-59M | $24M | $30M | $-76M | $40M | $-50M | $117M | $-13M | $13M | $-19M | |
| Stock Repurchased | $92M | $91M | $197M | $22M | $122M | $27M | $19M | $23M | $51M | $18M | $77M | $164M | $22M | $15M | $0 | $61M | |
| Net Stock Activity | $-92M | · | · | · | $-122M | · | · | · | $-51M | · | · | · | $-22M | · | · | · | |
| Financing Cash Flow | $-101M | $-93M | $-204M | $-30M | $-137M | $-30M | $-25M | $-20M | $-57M | $-14M | $-76M | $-161M | $-26M | $-12M | $779.0K | $-57M | |
| Net Change in Cash | $54M | $154M | $-104M | $32M | $-72M | $44M | $-19M | $73M | $15M | $-26M | $15M | $-198M | $149M | $22M | $63M | $-36M | |
| Taxes Paid | · | · | · | · | · | · | $14M | $9M | $13M | · | $9M | $29M | $0 | · | $2M | · | |
| Free Cash Flow | $42M | · | · | · | · | · | · | · | $41M | · | · | · | $57M | · | · | · |
Rentowność
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 84.9% | · | 89.9% | 90.2% | 89.2% | · | 91.6% | 90.0% | 89.3% | · | 91.0% | 88.8% | 87.9% | · | 88.3% | 87.1% | |
| Operating Margin | 21.5% | · | 38.9% | 37.8% | 37.4% | · | 47.4% | 38.8% | 36.4% | · | 43.3% | 29.7% | 27.4% | · | 33.4% | 31.4% | |
| Net Margin | 15.5% | · | 33.3% | 36.8% | 36.5% | · | 44.6% | 32.3% | 32.7% | · | 35.4% | 26.9% | 26.2% | · | 29.0% | 25.7% | |
| Pretax Margin | 25.8% | · | 43.7% | 43.3% | 44.0% | · | 53.3% | 45.4% | 42.0% | · | 46.6% | 34.9% | 31.8% | · | 35.5% | 32.3% | |
| EBITDA Margin | 24.2% | · | 38.9% | 37.8% | 39.3% | · | 47.4% | 38.8% | 38.4% | · | 43.3% | 29.7% | 29.8% | · | 33.4% | 31.4% | |
| ROA | 2.1% | · | 5.3% | 5.2% | 4.7% | · | 6.9% | 4.1% | 3.7% | · | 4.6% | 3.0% | 2.6% | · | 3.4% | 2.8% | |
| ROE | 2.5% | · | 6.1% | 6.0% | 5.5% | · | 7.9% | 4.8% | 4.3% | · | 5.3% | 3.5% | 3.0% | · | 3.8% | 3.2% | |
| ROIC | 2.2% | · | 5.6% | 5.0% | 4.4% | · | 6.5% | 3.9% | 3.9% | · | 5.1% | 3.0% | 2.5% | · | 3.4% | 2.9% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | · | 6.6 | 7.8 | 6.5 | · | 8.7 | 7.2 | 6.7 | · | 8.0 | 7.0 | 7.5 | · | 8.5 | 7.2 | |
| Quick Ratio | 3.0 | · | 1.5 | 2.1 | 1.7 | · | 2.6 | 2.3 | 1.7 | · | 2.1 | 1.7 | 3.0 | · | 2.0 | 1.3 |
Efektywność
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Receivables Turnover | 1.0 | · | 1.3 | 1.3 | 1.1 | · | 1.4 | 1.2 | 1.2 | · | 1.6 | 1.3 | 1.3 | · | 1.6 | 1.5 |
Na akcję
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.09 | · | $5.29 | $5.82 | $5.47 | · | $5.50 | $5.15 | $4.92 | · | $4.64 | $4.62 | $5.09 | · | $4.81 | $4.57 | |
| Revenue / Share | $0.82 | · | $0.93 | $0.84 | $0.73 | · | $0.83 | $0.68 | $0.64 | · | $0.67 | $0.54 | $0.51 | · | $0.54 | $0.48 | |
| Cash Flow / Share | $0.22 | · | · | · | $0.31 | · | · | · | $0.21 | · | · | · | $0.27 | · | · | · | |
| Cash / Share | $1.52 | · | $0.35 | $0.90 | $0.73 | · | $0.88 | $0.99 | $0.60 | · | $0.66 | $0.57 | $1.58 | · | $0.71 | $0.38 | |
| EPS (TTM) | $0.84 | · | $1.20 | $1.26 | $1.17 | · | $1.00 | $0.87 | $0.80 | · | $0.67 | $0.59 | $0.56 | · | $0.56 | $0.66 |
Wycena (TTM)
| Wskaźnik | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $656M | · | $638M | $621M | $590M | · | $550M | $517M | $494M | · | $468M | $448M | $437M | · | $402M | $384M | |
| Net Income TTM | $167M | · | $239M | $253M | $235M | · | $201M | $174M | $161M | · | $138M | $123M | $119M | · | $119M | $141M | |
| Market Cap | $3.73B | · | $8.19B | $13.76B | $11.50B | · | $10.02B | $8.14B | $5.19B | · | $5.22B | $4.00B | $6.62B | · | $6.49B | $5.81B | |
| P/E | 24.7 | · | 36.9 | 58.1 | 52.4 | · | 53.4 | 50.1 | 35.0 | · | 41.9 | 36.0 | 60.8 | · | 59.9 | 45.8 | |
| P/S | 5.7 | · | 12.8 | 22.1 | 19.5 | · | 18.2 | 15.7 | 10.5 | · | 11.1 | 8.9 | 15.2 | · | 16.1 | 15.1 | |
| P/B | 4.1 | · | 8.4 | 12.6 | 11.2 | · | 9.7 | 8.5 | 5.7 | · | 6.0 | 4.6 | 6.7 | · | 7.0 | 6.6 | |
| P / Tangible Book | 4.7 | · | 9.6 | 14.2 | 12.3 | · | 10.7 | 9.4 | 6.3 | · | 6.8 | 5.2 | 7.4 | · | 7.8 | 7.5 | |
| P / Cash Flow | 88.8 | · | · | · | 185.2 | · | · | · | 125.9 | · | · | · | 115.8 | · | · | · | |
| Earnings Yield | 4.0% | · | 2.7% | 1.7% | 1.9% | · | 1.9% | 2.0% | 2.9% | · | 2.4% | 2.8% | 1.7% | · | 1.7% | 2.2% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Przychody | $645M | $570M | $475M | $419M | $344M |
| Marża Brutto % | 89.1% | 90.2% | 89.3% | 87.2% | 88.4% |
| Marża Operacyjna % | 33.3% | 39.9% | 34.5% | 29.9% | 33.1% |
| Zysk netto | $196M | $223M | $148M | $113M | $155M |
| Rozwodniony EPS | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 |
| Wskaźnik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 6.1 | 7.0 | 6.2 | 7.0 | 8.1 |
| Wskaźnik Szybkości | 2.3 | 2.2 | 1.3 | 1.9 | 1.7 |
| Wskaźnik | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $326M | $273M | $184M | $178M | $125M |
Właściciele instytucjonalni (13F) 411 emitentów · $3.3B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
411
Wartość posiadanych akcji
$3.3B
Nowe pozycje
44
Zamknięte pozycje
100
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 44 (-51 vs poprzedni kw.) | 100 (-12 vs poprzedni kw.) | 132 (-36 vs poprzedni kw.) | 147 (+21 vs poprzedni kw.) | +3.0M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $588 281 276 | 13 285 485 | 17,59% | Akcje |
| BlackRock, Inc. | $296 729 585 | 14 307 116 | 8,87% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $132 468 433 | 6 387 099 | 3,96% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $123 971 960 | 5 977 433 | 3,71% | Akcje |
| D. E. Shaw & Co., Inc. | $122 826 179 | 5 922 188 | 3,67% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $96 385 189 | 4 647 309 | 2,88% | Akcje |
| STATE STREET CORP | $87 334 253 | 4 210 909 | 2,61% | Akcje |
| GOLDMAN SACHS GROUP INC | $84 762 882 | 4 086 928 | 2,53% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $79 848 140 | 3 849 310 | 2,39% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $65 022 244 | 3 135 113 | 1,94% | Akcje |
| DEUTSCHE BANK AG\ | $60 011 895 | 2 893 534 | 1,79% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $59 184 680 | 2 853 649 | 1,77% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $55 840 936 | 2 692 427 | 1,67% | Akcje |
| Carmignac Gestion | $48 861 366 | 2 355 900 | 1,46% | Akcje |
| FEDERATED HERMES, INC. | $48 345 085 | 2 331 007 | 1,45% | Akcje |
| MORGAN STANLEY | $46 575 609 | 2 245 689 | 1,39% | Akcje |
| LOOMIS SAYLES & CO L P | $45 345 771 | 2 186 392 | 1,36% | Akcje |
| Squarepoint Ops LLC | $45 090 336 | 2 174 076 | 1,35% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $42 902 785 | 2 068 601 | 1,28% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $42 682 967 | 1 831 887 | 1,28% | Akcje |
| Invesco Ltd. | $39 908 904 | 1 924 248 | 1,19% | Akcje |
| Amundi | $39 467 726 | 1 902 977 | 1,18% | Akcje |
| NORGES BANK | $39 178 461 | 1 889 029 | 1,17% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $37 860 213 | 1 838 767 | 1,13% | Akcje |
| Gotham Asset Management, LLC | $35 523 762 | 1 712 814 | 1,06% | Akcje |
| CITADEL ADVISORS LLC | $32 385 137 | 1 561 482 | 0,97% | Akcje |
| Iron Triangle Partners LP | $30 401 231 | 686 568 | 0,91% | Akcje |
| AXA Investment Managers S.A. | $29 339 221 | 401 083 | 0,88% | Akcje |
| Walleye Capital LLC | $29 032 972 | 1 399 854 | 0,87% | Akcje |
| BANK OF AMERICA CORP /DE/ | $28 029 302 | 1 351 461 | 0,84% | Akcje |
| Qube Research & Technologies Ltd | $26 585 445 | 1 281 844 | 0,80% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $24 611 432 | 1 186 665 | 0,74% | Akcje |
| NORTHERN TRUST CORP | $24 398 059 | 1 176 377 | 0,73% | Akcje |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $24 081 214 | 1 161 100 | 0,72% | Akcje |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $21 706 360 | 1 046 594 | 0,65% | Akcje |
| CITIGROUP INC | $21 132 360 | 1 018 918 | 0,63% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $21 106 040 | 1 017 649 | 0,63% | Akcje |
| Swedbank AB | $20 958 994 | 1 010 559 | 0,63% | Akcje |
| UBS Group AG | $18 868 401 | 909 759 | 0,56% | Akcje |
| JANE STREET GROUP, LLC | $18 450 221 | 889 596 | 0,55% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $17 517 170 | 844 608 | 0,52% | Akcje |
| JPMORGAN CHASE & CO | $16 959 200 | 817 890 | 0,51% | Akcje |
| Bank of New York Mellon Corp | $16 627 817 | 801 727 | 0,50% | Akcje |
| ALGERT GLOBAL LLC | $16 161 002 | 779 219 | 0,48% | Akcje |
| BANK OF NOVA SCOTIA | $15 850 607 | 764 253 | 0,47% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $14 559 480 | 702 000 | 0,44% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $13 859 558 | 668 303 | 0,41% | Akcje |
| Fundsmith LLP | $13 549 940 | 653 324 | 0,41% | Akcje |
| BAILLIE GIFFORD & CO | $13 349 820 | 643 675 | 0,40% | Akcje |
| Glenmede Investment Management, LP | $13 095 165 | 179 018 | 0,39% | Akcje |
Insiderzy spółki 15 insiderów · 8 dyrektorzy generalni · 6 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jeffrey Tangney | Chief Executive Officer | 15 sierpnia 2026 F | 2 531 955 | 0 | 0 | $0 |
| Matthew Sonefeldt | Chief Financial Officer | 15 sierpnia 2026 F | 486 238 | 0 | 0 | $0 |
| Anna Bryson | Chief Financial Officer | 15 lutego 2026 F | 505 549 | 0 | 0 | $0 |
| Steven L Zatz | President | 24 września 2026 A | 204 291 | 0 | 0 | $0 |
| Siddharth Sitaram | Chief Accounting Officer | 15 września 2026 C | 96 045 | 0 | 8 | $-419 352 |
| Craig Overpeck | Senior Vice President, Commercial Operations | 16 maja 2024 S | 108 609 | 0 | 0 | $0 |
| Paul W. Jorgensen | Chief Revenue Officer | 15 lutego 2023 F | 313 059 | 0 | 0 | $0 |
| Joseph B. Kleine | Chief Commercial Officer | 12 stycznia 2022 C | 441 760 | 0 | 0 | $0 |
| Watkin Phoebe L. Yang | Dyrektor | 30 września 2026 S | 24 744 | 0 | 1 | $-34 456 |
| Kira Scherer Wampler | Dyrektor | 1 września 2026 C | 27 923 | 0 | 9 | $-927 380 |
| Regina M. Benjamin | Dyrektor | 27 sierpnia 2026 A | 58 987 | 0 | 1 | $-354 200 |
| Kevin Spain | Dyrektor | 27 sierpnia 2026 A | 11 305 | 0 | 0 | $0 |
| Timothy S Cabral | Dyrektor | 27 sierpnia 2026 A | 11 305 | 0 | 2 | $-793 325 |
| Andreas Stavropoulos | Posiadacz 10% | 28 czerwca 2021 C | · | 0 | 0 | $0 |
| Gilbert H Kliman | · | 2 sierpnia 2022 D | 449 960 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 80 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| GRPM · Invesco Exchange-Traded Fund Trust | 2,03% | 352 435 SH | 1 października 2026 | Dziennie |
| LSEQ · Harbor ETF Trust | 2,02% | 14 749 NS | 31 lipca 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,37% | 686 526 NS | 31 lipca 2026 | N-PORT |
| SMLL · Harbor ETF Trust | 1,35% | 9 053 NS | 31 lipca 2026 | N-PORT |
| RNIN · EA Series Trust | 1,13% | 98 433 NS | 31 lipca 2026 | N-PORT |
| MCOW · Pacer Funds Trust | 1,03% | 525 NS | 31 lipca 2026 | N-PORT |
| XMHQ · Invesco Exchange-Traded Fund Trust | 0,73% | 1 377 723 SH | 1 października 2026 | Dziennie |
| BUL · Pacer Funds Trust | 0,49% | 30 738 NS | 31 lipca 2026 | N-PORT |
| IHF · iShares Trust | 0,48% | 257 076 SH | 11 września 2026 | Dziennie |
| RFG · Invesco Exchange-Traded Fund Trust | 0,43% | 49 865 SH | 1 października 2026 | Dziennie |
| COWG · Pacer Funds Trust | 0,33% | 349 670 NS | 31 lipca 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0,32% | 557 810 NS | 31 lipca 2026 | N-PORT |
| ESUM · Strategy Shares | 0,18% | 15 942 NS | 31 lipca 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,15% | 132 035 SH | 19 sierpnia 2026 | Dziennie |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,14% | 19 674 SH | 1 października 2026 | Dziennie |
| BKSE · BNY Mellon ETF Trust | 0,12% | 5 010 NS | 31 lipca 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 25 655 NS | 31 lipca 2026 | N-PORT |
| EWUS · iShares Trust | 0,11% | 52 582 SH | 11 września 2026 | Dziennie |
| VFQY · VANGUARD WELLINGTON FUND | 0,11% | 25 965 SH | 19 sierpnia 2026 | Dziennie |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,11% | 30 537 SH | 1 października 2026 | Dziennie |
| ESSC · Strategy Shares | 0,10% | 1 770 NS | 31 lipca 2026 | N-PORT |
| ISCG · iShares Trust | 0,10% | 39 666 SH | 11 września 2026 | Dziennie |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,10% | 33 755 NS | 31 lipca 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,08% | 97 882 NS | 31 lipca 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,08% | 76 205 SH | 1 października 2026 | Dziennie |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,08% | 215 901 SH | 19 sierpnia 2026 | Dziennie |
| PTMC · Pacer Funds Trust | 0,08% | 14 760 NS | 31 lipca 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,07% | 1 747 294 SH | 19 sierpnia 2026 | Dziennie |
| MIDU · Direxion Shares ETF Trust | 0,06% | 1 965 NS | 31 lipca 2026 | N-PORT |
| IYH · iShares Trust | 0,05% | 77 403 SH | 11 września 2026 | Dziennie |
| ESML · iShares Trust | 0,05% | 56 863 SH | 11 września 2026 | Dziennie |
| VFVA · VANGUARD WELLINGTON FUND | 0,05% | 21 465 SH | 19 sierpnia 2026 | Dziennie |
| SMMD · iShares Trust | 0,04% | 69 284 SH | 11 września 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,04% | 362 894 SH | 19 sierpnia 2026 | Dziennie |
| SMDX · Tidal Trust III | 0,04% | 2 374 NS | 31 lipca 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 57 235 NS | 31 lipca 2026 | N-PORT |
| WSML · iShares Trust | 0,03% | 53 898 SH | 11 września 2026 | Dziennie |
| IEUS · iShares Trust | 0,03% | 67 403 SH | 11 września 2026 | Dziennie |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,03% | 14 182 SH | 1 października 2026 | Dziennie |
| IWS · iShares Trust | 0,03% | 193 300 SH | 11 września 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 1 537 722 SH | 19 sierpnia 2026 | Dziennie |
| VB · VANGUARD INDEX FUNDS | 0,03% | 3 033 009 SH | 19 sierpnia 2026 | Dziennie |
| IWR · iShares Trust | 0,02% | 538 960 SH | 11 września 2026 | Dziennie |
| RILA · Spinnaker ETF Series | 0,02% | 446 NS | 31 lipca 2026 | N-PORT |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,02% | 68 821 SH | 1 października 2026 | Dziennie |
| LRND · New York Life Investments ETF Trust | 0,02% | 2 967 NS | 31 lipca 2026 | N-PORT |
| SCZ · iShares Trust | 0,01% | 2 047 043 SH | 11 września 2026 | Dziennie |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 2 102 305 SH | 19 sierpnia 2026 | Dziennie |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 78 419 SH | 19 sierpnia 2026 | Dziennie |
| DXUV · Dimensional ETF Trust | 0,01% | 2 526 NS | 31 lipca 2026 | N-PORT |
| IUSG · iShares Trust | 0,01% | 114 485 SH | 11 września 2026 | Dziennie |
| IWD · iShares Trust | 0,01% | 288 768 SH | 11 września 2026 | Dziennie |
| IYY · iShares Trust | 0,00% | 5 691 SH | 11 września 2026 | Dziennie |
| ITOT · iShares Trust | 0,00% | 179 485 SH | 11 września 2026 | Dziennie |
| IWB · iShares Trust | 0,00% | 90 563 SH | 11 września 2026 | Dziennie |
| IWV · iShares Trust | 0,00% | 36 814 SH | 11 września 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,00% | 99 952 NS | 31 lipca 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 3 539 NS | 31 lipca 2026 | N-PORT |
| IEUR · iShares Trust | 0,00% | 334 412 SH | 11 września 2026 | Dziennie |
| IDEV · iShares Trust | 0,00% | 905 897 SH | 11 września 2026 | Dziennie |
| DFUS · Dimensional ETF Trust | 0,00% | 23 098 NS | 31 lipca 2026 | N-PORT |
| IEFA · iShares Trust | 0,00% | 4 370 632 SH | 11 września 2026 | Dziennie |
| DCOR · Dimensional ETF Trust | 0,00% | 3 112 NS | 31 lipca 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 10 812 NS | 31 lipca 2026 | N-PORT |
| IXUS · iShares Trust | 0,00% | 862 826 SH | 11 września 2026 | Dziennie |
| TILT · FlexShares Trust | 0,00% | 158 NS | 31 lipca 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4 200 411 SH | 19 sierpnia 2026 | Dziennie |
| VXUS · VANGUARD STAR FUNDS | 0,00% | 7 970 190 SH | 19 sierpnia 2026 | Dziennie |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 1 396 695 SH | 19 sierpnia 2026 | Dziennie |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 598 294 SH | 19 sierpnia 2026 | Dziennie |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,00% | 5 431 499 SH | 19 sierpnia 2026 | Dziennie |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,00% | 22 610 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 10 642 SH | 19 sierpnia 2026 | Dziennie |
| VSGX · VANGUARD WORLD FUND | 0,00% | 95 335 SH | 19 sierpnia 2026 | Dziennie |
| ESGV · VANGUARD WORLD FUND | 0,00% | 29 384 SH | 19 sierpnia 2026 | Dziennie |
| IJH · iShares Trust | · | 4 694 508 SH | 11 września 2026 | Dziennie |
| IJK · iShares Trust | · | 774 827 SH | 11 września 2026 | Dziennie |
| XJH · iShares Trust | · | 18 322 SH | 8 września 2026 | Dziennie |
| ISCB · iShares Trust | · | 5 605 SH | 11 września 2026 | Dziennie |
| SMLF · iShares Trust | · | 103 220 SH | 11 września 2026 | Dziennie |
DOCS Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 28 analityków
KUP
Średni cel
$28.00
+0,3%
4 14,3%
Mocne kupno
10 35,7%
Kup
12 42,9%
Trzymaj
2 7,1%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
18 analityków · 2026-10-03Średnia cel $29.67 +6,2%
Teraz
Aktualna cena $27.93
Niski$18.00
Średnia$29.67
Wysoki$47.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| DOCS | $4.27B | 23.8 | 13.1% | 30.4% | 19.2% | 89.1% |
| VEEV | $33.40B | 37.5 | 16.3% | 28.4% | 13.1% | 75.5% |
| WAY | $6.27B | 53.7 | 16.5% | 10.2% | 3.2% | · |
| HTFL | $2.49B | -9.2 | 39.9% | -66.3% | 39.3% | 76.8% |
| SDGR | · | -12.7 | 23.3% | -40.4% | -29.2% | 55.7% |
| CERT | $1.40B | -881.0 | 8.8% | -0.38% | -0.15% | · |
| GDRX | · | 30.1 | 0.57% | 3.8% | 4.8% | · |
| TDOC | $1.25B | -6.1 | -1.5% | -7.9% | -14.3% | · |
| HSTM | $682M | 37.8 | 4.3% | 6.0% | 5.2% | · |
| PHR | · | 335.8 | 14.5% | 0.48% | 0.73% | · |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 6, 2026